Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joshua Reed currently holds 27,492 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua Reed has been a net buyer of ALDX stock. They have purchased $15.1K and sold $0 worth of shares.
Joshua Reed's most recent insider trade was on Oct 8, 2026, when they sold 9,164 shares at $0.00 per share.
Joshua Reed serves as Executive at Aldeyra Therapeutics, Inc. (ALDX). They have executed 12 insider transactions totaling $15.1K over their tenure at the company.
Joshua Reed holds the position of Executive at Aldeyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Joshua Reed has shown a buying trading pattern, with $15.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Joshua Reed was on Oct 8, 2026, when they sold $163.2K worth of ALKS shares. This transaction involved 4,069 shares at $40.11 per share.
Joshua Reed currently owns 27,492 shares of Aldeyra Therapeutics, Inc. (ALDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joshua Reed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joshua Reed has 12 Form 4 filings on record as an insider at Aldeyra Therapeutics, Inc..
Set alerts for Joshua Reed and 40,000+ other insiders.